These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 7670532)

  • 1. Molecular basis of Trypanosoma cruzi-induced immunosuppression. Altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle.
    Kierszenbaum F; Moretti E; Sztein MB
    Biol Res; 1993; 26(1-2):197-207. PubMed ID: 7670532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes.
    Sztein MB; Cuna WR; Kierszenbaum F
    J Immunol; 1990 May; 144(9):3558-62. PubMed ID: 2139458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Trypanosoma cruzi-induced down-regulation of lymphocyte function. Inhibition of transcription and expression of IL-2 receptor gamma (p64IL-2R) and beta (p70IL-2R) chain molecules in activated normal human lymphocytes.
    Majumder S; Kierszenbaum F
    J Immunol; 1996 May; 156(10):3866-74. PubMed ID: 8621925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosomal immunosuppressive factor: a secretion product(s) of Trypanosoma cruzi that inhibits proliferation and IL-2 receptor expression by activated human peripheral blood mononuclear cells.
    Kierszenbaum F; Cuna WR; Beltz LA; Sztein MB
    J Immunol; 1990 May; 144(10):4000-4. PubMed ID: 2185317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production.
    Van Voorhis WC
    J Immunol; 1992 Jan; 148(1):239-48. PubMed ID: 1727869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mechanism for Trypanosoma cruzi-induced suppression of human lymphocytes. Inhibition of IL-2 receptor expression.
    Beltz LA; Sztein MB; Kierszenbaum F
    J Immunol; 1988 Jul; 141(1):289-94. PubMed ID: 3132504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosoma cruzi reduces the number of high-affinity IL-2 receptors on activated human lymphocytes by suppressing the expression of the p55 and p70 receptor components.
    Kierszenbaum F; Cuna WR; Beltz LA; Sztein MB
    J Immunol; 1989 Jul; 143(1):275-9. PubMed ID: 2659667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes.
    Sztein MB; Kierszenbaum F
    Immunology; 1992 Oct; 77(2):277-83. PubMed ID: 1427979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A soluble factor from Trypanosoma brucei rhodesiense that prevents progression of activated human T lymphocytes through the cell cycle.
    Sztein MB; Kierszenbaum F
    Immunology; 1991 Jun; 73(2):180-5. PubMed ID: 2071163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease.
    Kierszenbaum F; Lopez HM; Sztein MB
    Immunology; 1994 Mar; 81(3):462-7. PubMed ID: 8206517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
    Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M
    Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of murine T cell subsets with anti-CD3 antibody. Age-related defects in the expression of early activation molecules.
    Ernst DN; Weigle WO; McQuitty DN; Rothermel AL; Hobbs MV
    J Immunol; 1989 Mar; 142(5):1413-21. PubMed ID: 2521878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective suppressive effects of Trypanosoma cruzi infection on IL-2, c-myc, and c-fos gene expression.
    Soong L; Tarleton RL
    J Immunol; 1992 Sep; 149(6):2095-102. PubMed ID: 1517573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro expression of an interleukin 2 receptor by murine B and T lymphocytes.
    Finkelman FD; Malek TR; Shevach EM; Mond JJ
    J Immunol; 1986 Oct; 137(7):2252-9. PubMed ID: 3093569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
    Tao X; Davis LS; Hashimoto K; Lipsky PE
    J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma cruzi: the effect of nitric oxide synthesis inhibition on the CD4 T cell response to the trans-sialidase superfamily.
    Millar AE; Kahn SJ
    Exp Parasitol; 2000 Feb; 94(2):84-91. PubMed ID: 10673344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acquisition of cytokine responsiveness by murine B cells: a role for antigen and IL-5 in the induction of IL-2 receptors.
    Poudrier J; Owens T
    Immunology; 1994 Mar; 81(3):373-80. PubMed ID: 8206511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of soluble mediator(s) different from interleukin (IL) 1 in the antigen-induced IL 2 receptor expression and proliferation of L3T4+ (CD4+) T lymphocytes.
    Germann T; Schmitt E; Huhn H; Rüde E
    Eur J Immunol; 1988 Mar; 18(3):459-65. PubMed ID: 3128448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treponema denticola immunoinhibitory protein induces irreversible G1 arrest in activated human lymphocytes.
    Lee W; Pankoski L; Zekavat A; Shenker BJ
    Oral Microbiol Immunol; 2004 Jun; 19(3):144-9. PubMed ID: 15107064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective suppressive effects of Trypanosoma cruzi on activated human lymphocytes.
    Beltz LA; Kierszenbaum F; Sztein MB
    Infect Immun; 1989 Aug; 57(8):2301-5. PubMed ID: 2663720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.